Published On: Fri, Dec 27th, 2013

Health Enhancement Products, Inc. (OTCQB: HEPI) Enters Into Collaborative Agreement with Global Animal Health Company to Accelerate Bovine Mastitis Product

Health Enhancement Products, Inc. (OTCQB: HEPI), a health and wellness company engaged in the development of natural bioactive compounds for use as dietary supplements and food ingredients, as well as biologics for medicinal and pharmaceutical applications in humans and animals, announced Thursday, December 26th, 2013, that it entered into a collaborative/option agreement with a global animal health company, whose name is being withheld for competitive considerations and intellectual property protection for both parties.

Under the terms if the agreement, Health Enhancement Products will be allowed to move forward with validation and product development in direct collaboration with scientists from the animal health company. This will take place at pre-determined intervals of 90 days per evaluation period and negotiation period, which may culminate in a final licensing arrangement.  Additional opportunities to further disclose aspects of the agreement may occur.

The agreement will also provide for a licensing option covering bovine applications across a range of modalities and includes the company’s natural compound, the proprietary refined algal extract and the synthetic molecules developed by Health Enhancement. Additional details may be released over the next few weeks.

© Copyright 2016 OTC News Magazine. All rights reserved.